Top 15 Companies in Global Brucella Abortus Vaccine Market: Statistics Report Till 2035

Description

According to a research report published by Spherical Insights & Consulting, the Global Brucella Abortus Vaccine Market Size is projected to grow from USD 331.4 Million in 2025 to USD 589.2 Million by 2035, at a CAGR of 5.92% during the forecast period 2026–2035. The Brucella abortus vaccine market is driven by increasing global prevalence of brucellosis in livestock, surging demand for animal products, and rising zoonotic infection rates in humans.

 

Introduction

The worldwide market for brucella abortus vaccines includes vaccines and products that protect against brucellosis, which is a highly contagious disease that can spread from animals to humans. The market focuses on protecting livestock, including cattle, bison, and buffalo from this zoonotic disease. The Brucella abortus vaccine market remains active because India's National Animal Disease Control Programme uses its central funding of ₹13,343 crore to vaccinate across India, which creates a need for livestock vaccines and helps disease control programs. Government vaccination programs drive market demand for vaccines. The nationwide vaccination program of India between 2019 and 2024 aims to achieve 100% vaccination of female calves against brucellosis and FMD through a budget of USD 1.60 billion, which will support mass vaccine distribution. The market is expanding at a 4 to 5 percent compound annual growth rate because of increased global brucellosis outbreaks and government vaccination requirements for cattle and the protection needs of farmers and veterinarians. The company can achieve its primary goals through three main opportunities, which involve developing safe DIVA vaccines that differentiate infected from vaccinated animals, expanding operations into India and Africa, and implementing digital vaccine tracking systems.

 

Navigate Future Markets with Confidence: Insights from Spherical Insights LLP

The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Brucella Abortus Vaccine Market.

 

Brucella Abortus Vaccine Market Size & Statistics

• The Market Size for Brucella Abortus Vaccine Was Estimated to be worth USD 331.4 Million in 2025.
• The Market is Going to Expand at a CAGR of 5.92% between 2026 and 2035.
• The Global Brucella Abortus Vaccine Market Size is anticipated to reach USD 589.2 Million by 2035.
• North America is expected to generate the largest demand during the forecast period in the Brucella Abortus Vaccine Market.
• Asia Pacific is expected to grow the fastest during the forecast period in the Brucella Abortus Vaccine Market.

 

Market Segmentation:

Global Brucella Abortus Vaccine Market Size, Share, By Type (Live Attenuated Vaccines and Inactivated Vaccines), By Application (Veterinary Medicine, Agriculture, and Animal Health), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2026 - 2035

 

Regional growth and demand

Asia Pacific is expected to grow the fastest during the forecast period in the brucella abortus vaccine market. In Dec 2025, India’s Department of Biotechnology reported MEV1 and MEV2 multi-epitope vaccines showing strong protection against Brucella abortus and B. melitensis in immunogenicity and challenge studies. In March 2026, the Government of India highlighted centralized procurement and supply of brucellosis vaccines under the Livestock Health and Disease Control Programme, improving coverage and significantly reducing outbreaks nationwide. The Asia Pacific region dominated the brucella abortus vaccine market due to a high concentration of livestock, particularly cattle and buffalo, combined with a high prevalence of brucellosis in the region.

 

North America is expected to generate the largest demand during the forecast period in the brucella abortus vaccine market. In Dec 2025, Colorado Serum Company and regional players advanced improved Brucella vaccine formulations focusing on safety and efficacy, reflecting incremental innovation rather than new commercial product launches. In 2024, Merck Animal Health and Zoetis continued the distribution of RB51-based vaccines across North America, supporting eradication programs and maintaining dominance of established vaccine platforms in the region. The North America region holds the largest share in the brucella abortus vaccine market due to high investments in animal health infrastructure, stringent regulatory requirements for livestock testing and vaccination, and a high concentration of key industry players.

 

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Brucella Abortus Vaccine Market.

 

Top 10 Trends in the Brucella Abortus Vaccine Market

1. Increasing government-led livestock vaccination programs
2. Rising adoption of RB51 and advanced vaccine strains
3. Growth in veterinary healthcare infrastructure
4. Integration of biotechnology in vaccine development
5. Rising awareness of zoonotic disease prevention
6. Expansion of dairy and livestock industries
7. Public-private partnerships in animal health
8. Development of thermostable vaccines
9. Increased funding for livestock disease eradication
10. Digital tracking of vaccination programs

 

Increasing government-led livestock vaccination programs

Governments across developing economies are implementing large-scale immunization campaigns to control Brucellosis, driving consistent demand for vaccines and improving livestock health outcomes globally.

 

Rising adoption of RB51 and advanced vaccine strains

Modern vaccine strains such as RB51 are gaining adoption due to improved safety, better immune response, and reduced interference with diagnostic testing in livestock populations.

 

Growth in veterinary healthcare infrastructure

Expansion of veterinary hospitals, diagnostic labs, and cold-chain systems is improving vaccine accessibility and supporting large-scale livestock immunization programs globally.

 

Integration of biotechnology in vaccine development

Biotech advancements are enabling development of more effective, stable, and long-lasting vaccines, enhancing disease prevention and livestock productivity.

 

Rising awareness of zoonotic disease prevention

Increasing awareness of disease transmission from animals to humans is encouraging preventive vaccination, particularly in dairy and meat production industries.

 

Empower your strategic planning:

Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the brucella abortus vaccine market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Brucella Abortus Vaccine Market.

 

Top 15 Companies Leading the Brucella Abortus Vaccine Market

1. Zoetis Inc.
2. Merck Animal Health
3. Boehringer Ingelheim Animal Health
4. Elanco Animal Health
5. Ceva Sante Animale
6. Indian Immunologicals Ltd.
7. Hester Biosciences Ltd.
8. Biovet Pvt. Ltd.
9. Colorado Serum Company
10. Vetal Animal Health Products
11. HIPRA
12. CZ Vaccines
13. Agrovet Market Animal Health
14. Jinyu Bio-Technology Co., Ltd.
15. Phibro Animal Health Corporation

 

1. Zoetis Inc.

Headquarters: Parsippany, New Jersey, USA

Founded in 1952, Zoetis Inc. is a global leader in animal health with approximately 13,800 employees worldwide. The company reported nearly USD 8.5 billion in revenue in 2025. Zoetis focuses on livestock vaccines, including brucellosis prevention solutions, and advanced biologics. Key projects include next-generation vaccine development and large-scale immunization programs for cattle health. The company operates in more than 100 countries, with major market presence in the United States, China, India, Brazil, and key European nations, supporting livestock productivity, disease prevention, and sustainable farming practices across global agricultural industries.

 

2. Merck Animal Health

Headquarters: Rahway, New Jersey, USA

Established as part of Merck & Co., Inc. in 1891, Merck Animal Health employs around 10,000 professionals globally. In 2025, the division contributed significantly to Merck’s USD 60+ billion total revenue. The company develops veterinary vaccines, including brucellosis control solutions, along with digital livestock monitoring tools. Key projects include integrated animal health platforms and precision livestock technologies. It operates in over 50 countries, with strong presence in the United States, Canada, Germany, Brazil, and India, supporting efficient disease management and enhancing livestock health outcomes globally.

 

3. Boehringer Ingelheim Animal Health

Headquarters: Ingelheim, Germany

Founded in 1885, Boehringer Ingelheim employs approximately 52,000 people globally, with its animal health division playing a key role in operations. The company generated around USD 25 billion in total revenue in 2025. It develops advanced veterinary vaccines, including solutions for zoonotic diseases such as brucellosis. Key projects include biologics research and global immunization initiatives for livestock. Boehringer operates in more than 150 countries, with major markets in Germany, the United States, France, China, and Brazil, supporting sustainable livestock production and strengthening animal health systems worldwide.

 

4. Elanco Animal Health

Headquarters: Greenfield, Indiana, USA

Elanco Animal Health was founded in 1954 and employs approximately 9,000 people globally. The company reported around USD 4.5 billion in revenue in 2025. Elanco specializes in livestock vaccines and disease prevention products, including solutions targeting bacterial infections like brucellosis. Key projects include sustainable livestock health programs and antibiotic alternatives. The company operates in more than 90 countries, with key markets in the United States, Brazil, China, India, and Europe, supporting improved farm productivity, animal welfare, and global food security initiatives.

 

5. Ceva Sante Animale

Headquarters: Libourne, France

Founded in 1999, Ceva Sante Animale employs over 7,000 people worldwide and generated approximately USD 1.7 billion in revenue in 2025. The company develops veterinary vaccines and pharmaceuticals, including brucellosis prevention solutions for livestock. Key projects include innovative vaccine platforms and global immunization campaigns. Ceva operates in more than 110 countries, with strong presence in France, China, Brazil, India, and the United States, supporting livestock health management, improving disease control strategies, and expanding access to veterinary care in emerging markets.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Brucella Abortus Vaccine Market.

 

Are you ready to discover more about the brucella abortus vaccine market?

The report provides an in-depth analysis of the leading companies operating in the global brucella abortus vaccine market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:

 

Company Profiles

1. Zoetis Inc.

• Business Overview
• Company Snapshot
• Products Overview
• Company Market Share Analysis
• Company Coverage Portfolio
• Financial Analysis
• Recent Developments
• Merger and Acquisitions
• SWOT Analysis

2. Merck Animal Health
3. Boehringer Ingelheim Animal Health
4. Elanco Animal Health
5. Ceva Sante Animale
6. Indian Immunologicals Ltd.
7. Hester Biosciences Ltd.
8. Biovet Pvt. Ltd.
9. Colorado Serum Company
10. Others

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Brucella Abortus Vaccine Market.

 

Conclusion

The global Brucella abortus vaccine market is positioned for steady growth through 2035. The market expansion will be driven by increasing livestock disease occurrences, strong government vaccination programs, and rising public understanding of zoonotic disease prevention methods. The Indian brucellosis control campaign, together with similar programs in developing countries, works to promote vaccine usage at an accelerated pace. North America maintains its market leadership because of its superior animal health systems and key companies like Zoetis Inc and Merck Animal Health. Asia Pacific ranks as the fastest-growing market because of its substantial livestock numbers and government backing. The introduction of DIVA vaccines combined with digital tracking technologies will boost disease control capabilities, which will secure continuous market development and better international livestock health results.

 

Our Reports:

Styrene Acrylonitrile Market Size, Growth, Forecast to 2035
Triethylamine Market Size,Growth, Forecast to 2035
Sunflower Lecithin Market Size, Growth, Forecast to 2035
Petroleum Resin Market Size, Growth, Forecast to 2035

 

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI. Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter